Banks Vie With Private Debt to Offer €3 Billion for Zentiva Sale

Lenders are preparing debt financing of up to €3 billion to back a potential sale of generic drugmaker Zentiva as a deal draws nearer.

Banks including Goldman Sachs Group Inc. are competing with private credit firms to finance potential buyers, as final bids in an auction process are due shortly, according to people familiar with the matter. The sale by Zentiva’s owner Advent International has attracted interest from investors such as GTCR and TPG Inc. Indian drugmaker Aurobindo Pharma Ltd. was also thought to be around the process, Bloomberg reported previously.